Answer
Lupkynis (voclosporin) is licensed, in combination with mycophenolate mofetil, to treat adults with active class III, IV or V lupus nephritis, including mixed class III/V and IV/V.
Sources for this answer
- Lupkynis 7.9 mg soft capsulesOtsuka Pharmaceuticals (UK) Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 7Document updated
Sources checked